A 8-week, Rater-blind, Active-controlled, Randomized Study to Compare the Effectiveness of Venlafaxine With Fluoxetine in the Treatment of Postmenopausal Women With Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Fluoxetine (Primary) ; Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 01 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 01 Aug 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jun 2017.
- 28 Jul 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov